Phage therapy experience at the Eliava Institute.
The rapid spread of multidrug resistant bacterial strains limits the effectiveness of antibiotic treatments and induces intense research for alternatives. Today, the use of phage preparations as alternative approach is gaining attention, particularly for treating a wide variety of diseases which are difficult to control by chemotherapeutic agents. This article relates the phage therapy experience of the Eliava Institute of Bacteriophage, Microbiology and Virology.
Kutateladze
M
M
Eliava IBMV, 3, Gotua street, Tbilisi 0160, Georgia. kutateladze@pha.ge
Adamia
R
R
D001435:Bacteriophages / Q000502:physiology*; D003141:Communicable Diseases / Q000628:therapy*; D003550:Cystic Fibrosis / Q000628:therapy / Q000821:virology; D005846:Georgia (Republic); D006801:Humans; D008242:Lysogeny; D013203:Staphylococcal Infections / Q000628:therapy; D013210:Staphylococcus / Q000821:virology